ACCPL — Accretion Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Accretion Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IAS	IAS	IAS
Status:	Final	Final	Final
Cash
Cash and Short Term Investments	3.75	0.364	0.916
Net Total Accounts Receivable
Net Total Receivables	45.7	66.6	68.5
Total Inventory
Total Other Current Assets
Total Current Assets	119	145	216
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	58.4	60.1	52.7
Long Term Notes Receivable
Other Long Term Assets
Total Assets	177	206	270
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	117	138	147
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	147	167	217
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	30.8	38.4	53.5
Total Liabilities & Shareholders' Equity	177	206	270
Total Common Shares Outstanding